Cargando…
Integrin β6 serves as an immunohistochemical marker for lymph node metastasis and promotes cell invasiveness in cholangiocarcinoma
Cholangiocarcinoma is a devastating malignancy that is notoriously difficult to diagnose and is associated with a high mortality. Despite extensive efforts to improve the diagnosis and treatment of this neoplasm, limited progress has been made. Integrin β6 is a subtype of integrin that is expressed...
Autores principales: | Li, Zequn, Biswas, Siddhartha, Liang, Benjia, Zou, Xueqing, Shan, Liqun, Li, Yang, Fang, Ruliang, Niu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4954992/ https://www.ncbi.nlm.nih.gov/pubmed/27440504 http://dx.doi.org/10.1038/srep30081 |
Ejemplares similares
-
Integrin αvβ8 serves as a Novel Marker of Poor Prognosis in Colon Carcinoma and Regulates Cell Invasiveness through the Activation of TGF-β1
por: Zhou, Mingliang, et al.
Publicado: (2020) -
Integrin αvβ6 plays a bi-directional regulation role between colon cancer cells and cancer-associated fibroblasts
por: Peng, Cheng, et al.
Publicado: (2018) -
The influence of the extent of lymph node metastasis on the prognosis for patients with intrahepatic cholangiocarcinoma
por: Wang, Jianping, et al.
Publicado: (2023) -
Intrahepatic cholangiocarcinoma patients without indications of lymph node metastasis not benefit from lymph node dissection
por: Hu, Jie, et al.
Publicado: (2017) -
Integrins and Their Extracellular Matrix Ligands in Lymphangiogenesis and Lymph Node Metastasis
por: Chen, Jie, et al.
Publicado: (2012)